Research · Randomized controlled trial
Using pyridoxine to treat carpal tunnel syndrome: randomized control trial
What it found
No difference from placebo in symptoms, clinical signs, or electrophysiology — the findings did not support pyridoxine for carpal tunnel syndrome.
- Design
- Randomized controlled trial
- Year
- 1993
- Sample size
- 32
- Population
- patients with idiopathic carpal tunnel syndrome
- Intervention
- pyridoxine 200 mg/day for 12 weeks vs placebo
- Outcome
- symptoms, clinical signs, nerve conduction
- Journal
- Canadian Family Physician
Citation last checked 2026-06-21.